ClinicalTrials.gg
RecruitingNCT07541027Updated Sep 25, 2026

A Mindfulness-based Intervention for Hotel Staff

An interventional study of A mindfulness-based intervention in Well-Being (Psychological Flourishing), Work Related Stress and Work Performance, sponsored by Chinese University of Hong Kong. Recruiting at 1 site in Hong Kong. Open to participants aged 18 Years to 18 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-09-25.

Sponsored by Chinese University of Hong Kong · Not applicable, Interventional, and Treatment

Updated Sep 25, 2026Now RecruitingSite recruiting status changed+1 moreGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Randomized
Ages
18 Years to 18 Years
Sex
All
01

Study summary

This research aims to investigate the potential impact of a structured mindfulness-based professional development program on hotel employees and to explore why and how these changes occur during and after the mindfulness intervention through a mixed-methods approach. A 6-week mindfulness intervention with 60 hotel staff from a hotel will be implemented in Hong Kong. Both quantitative and qualitative data will be collected to examine changes in job-related outcomes, wellbeing, and state mindfulness and teachers' lived experiences and perspectives associated with this intervention. Data will be analyzed based on convergent parallel mixed-method approach, such as mixed-effects modeling, mediation analysis, and thematic analysis. This study may provide practical implications for developing evidence-based programs to promote wellbeing and service quality among hotel employees.

02

Conditions studied

  • Well-Being (Psychological Flourishing)
  • Work Related Stress
  • Work Performance

Browse trials for

03

In context

Occupational Stress

236 studies on the registry are indexed under Occupational Stress; 63 are open to participants now.

This study's planned enrollment of 60 is below the median of 84 across 168 interventional studies indexed under Occupational Stress.

Browse Occupational Stress studies →

Lead sponsor

Chinese University of Hong Kong is the lead sponsor of 1,454 studies on the registry; 474 are open to participants now.

Of its 6 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 18 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Aged 18 years or above
  • Currently working in a hotel
  • Cantonese speaker
  • Willing to commit time for the 6-week mindfulness course

Exclusion criteria

Exclusion Criteria:

  • Individuals who had previously joined a related group mindfulness-based intervention, such as mindfulness-based cognitive therapy (MBCT), mindfulness-based stress reduction (MBSR), or Mindfulness - Finding Peace in a Frantic World (FPFW)
  • Staff members who are mentally unstable or having active suicidal risk
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
60 participants (estimated)

Study arms

  • Experimental
    A mindfulness-based intervention

    Behavioral: A mindfulness-based intervention

  • No intervention
    Waitlist control

    It is a waitlist control condition.

Interventions

  • BehavioralA mindfulness-based intervention

    This is a 6-week mindfulness-based program consisting of mindfulness practices, cognitive-behavioral techniques, and other psychological exercises with 6 sessions (1 hour/session)

06

What researchers measure

Primary outcomes

  1. Emotional Labor Scale (ELS)

    It is used to measure the emotional labor strategies of participants and the scale contains 11 items organized in two subscales: Surface Acting and Deep Acting. Participants will rate their responses on a 5-point Likert scale ranging from 1 (strongly disagree) to 5 (strongly agree). The total score of the Surface Acting subscale ranges from 7 to 35 and the total score of the Deep Acting subscale ranges from 4 to 20. A higher total score on each subscale indicates a higher tendency to use that particular strategy.

    Time frame: Week 0, Week 6, and Week 10

  2. Professional Efficacy Subscale of the Maslach Burnout Inventory- General Survey (MBI-GS)

    It is used to measure participants' professional efficacy. The scale consists of 6 items on a 7-point Likert scale ranging from 0 (never) to 6 (everyday). The total score ranges from 0 to 36. A higher score indicates a higher level of professional efficacy.

    Time frame: Week 0, Week 6, and Week 10

  3. Nature of Work Subscale of Job Satisfaction Survey (JSS)

    It is used to measure participants' job satisfaction. The scale contains 4 items on a 6-point Likert scale from 1 (disagree very much) to 6 (agree very much). The total score ranges from 4 to 24. A higher total score indicates a greater job satisfaction.

    Time frame: Week 0, Week 6, and Week 10

Secondary outcomes

  1. The Perceived Stress Scale (PSS-10)

    It is used to measure participants' perceived stress levels. Participates rate their stress on a 5-point Likert scale ranging from 0 (never) to 4 (very often). The total score ranges from 0 to 40. A higher total score indicates higher stress levels.

    Time frame: Week 0, Week 6, and Week 10

  2. The Generalized Anxiety Disorder-7 (GAD-7)

    It is used to measure participants' anxiety symptoms. The scale contains 7 items on a 4-point Likert scale ranging from 0 (not at all) to 3 (nearly every day) over the past two weeks. The total score ranges from 0 to 21. A higher total score indicates a higher level of anxiety.

    Time frame: Week 0, Week 6, and Week 10

  3. Patient Health Questionnaire-9 (PHQ-9)

    It is used to measure participants' depressive symptoms. The scale contains 9 items on a 4-point Likert scale ranging from 0 (not at all) to 3 (nearly every day) over the past two weeks. The total score ranges from 0 to 27. A higher total score indicates higher depressive symptoms.

    Time frame: Week 0, Week 6, Week 10

  4. The Chinese version of the State Mindfulness Scale

    It is used to measure participants' state mindfulness. Participants give ratings on a 5-point Likert scale from 1 (not at all) to 5 (very much). The total score ranges from 21 to 105. A higher total score means a higher level of state mindfulness.

    Time frame: Week 0, Week 6, and Week 10

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it movedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Sep 2026; primary completion for Feb 2027, 5 months later.

Of 125 non-industry interventional studies with no phase under Occupational Stress, half reached primary completion within 10 months of starting (the median), counting those still running; a quarter within 4 and three quarters within 28. This study's planned 5 months is below that.

Counting every sponsor, half of 133 studies reached it within 10 months; a quarter within 5 and three quarters within 27.

Start moved once since we started tracking on Sep 25, 2026: Jun 2026 → Sep 2026, on Sep 25, 2026.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Apr 15, 2026
First posted
Apr 21, 2026
StartEst.
Sep 23, 2026was Jun 2026
Primary completionEst.
Feb 28, 2027
CompletionEst.
May 31, 2027
Last update
Sep 25, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Status
Not yet recruiting→Recruiting
changed Sep 25, 2026
Sites
The Chinese University of Hong Kong is now Recruiting
Sep 25, 2026
Start date
Jun 1, 2026→Sep 23, 2026
Sep 25, 2026
Show all 1 update
  1. Sep 25, 2026
    Not yet recruiting→Recruiting
    The Chinese University of Hong Kong is now Recruiting
    Start date Jun 1, 2026→Sep 23, 2026
    + 1 other change: verification date

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07541027
Responsible party
Jennifer Yee Man Tang (Assistant Professor, Chinese University of Hong Kong) — Principal investigator
First posted
Apr 21, 2026
Start date
Sep 23, 2026 (estimated)
Primary completion
Feb 28, 2027 (estimated)
Completion
May 31, 2027 (estimated)
Last update
Sep 25, 2026

Study contacts

Jennifer Yee Man Tang, PhD
Contact
jymtang@cuhk.edu.hk
+852 39436904

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion